Improving management of diabetic kidney disease: will GLP-1 receptor agonists have a role?

被引：4
|
作者：
Bellary, Srikanth [1 ,2 ]
Tahrani, Abd A. [2 ,3 ,4 ]
Barnett, Anthony H. [2 ,3 ]
机构：
[1] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England
[2] Univ Hosp Birmingham NHS Fdn Trust, Birmingham, W Midlands, England
[3] Univ Birmingham, Inst Metab & Syst Res, Birmingham, W Midlands, England
[4] Birmingham Hlth Partners, Ctr Endocrinol Diabet & Metab CEDAM, Birmingham, W Midlands, England
来源：
LANCET DIABETES & ENDOCRINOLOGY | 2020年 / 8卷 / 11期
关键词：
LIRAGLUTIDE; OUTCOMES;
D O I：
10.1016/S2213-8587(20)30301-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：870 / 871
页数：2
相关论文
共 50 条
  • [1] GLP-1 Receptor Agonists in Diabetic Kidney Disease
    Michos, Erin D.
    Tuttle, Katherine R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 16 (10): : 1578 - 1580
  • [2] GLP-1 Receptor Agonists and Diabetic Kidney Disease: A Call of Attention to Nephrologists
    Gorriz, Jose Luis
    Jose Soler, Maria
    Navarro-Gonzalez, Juan F.
    Garcia-Carro, Clara
    Jesus Puchades, Maria
    D'Marco, Luis
    Martinez Castelao, Alberto
    Fernandez-Fernandez, Beatriz
    Ortiz, Alberto
    Gorriz-Zambrano, Carmen
    Navarro-Perez, Jorge
    Jose Gorgojo-Martinez, Juan
    JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
  • [3] GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Physiology to Clinical Outcomes
    Rojano Toimil, Alba
    Ciudin, Andreea
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (17)
  • [4] GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions
    Yu, Ji Hee
    Park, So Young
    Lee, Da Young
    Kim, Nan Hee
    Seo, Ji A.
    KIDNEY RESEARCH AND CLINICAL PRACTICE, 2022, 41 (02) : 136 - 149
  • [5] The impact of GLP-1 receptor agonists on metabolic control and diabetic kidney disease progression
    Venda, Joao
    Henriques, Andreia Dos Santos
    Monsanto, Alice
    Pompermayer, Micael
    Leal, Rita
    Alves, Rui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1204 - I1204
  • [6] The impact of GLP-1 receptor agonists on metabolic control and diabetic kidney disease progression
    Venda, Joao
    Henriques, Andreia Dos Santos
    Monsanto, Alice
    Pompermayer, Micael
    Leal, Rita
    Alves, Rui
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [7] GLP-1 Receptor Agonists in Diabetic Kidney Disease: From Clinical Outcomes to Mechanisms
    Kawanami, Daiji
    Takashi, Yuichi
    FRONTIERS IN PHARMACOLOGY, 2020, 11
  • [8] GLP-1 Receptor Agonists and Kidney Protection
    Greco, Eulalia Valentina
    Russo, Giuseppina
    Giandalia, Annalisa
    Viazzi, Francesca
    Pontremoli, Roberto
    De Cosmo, Salvatore
    MEDICINA-LITHUANIA, 2019, 55 (06):
  • [9] Role and development of GLP-1 receptor agonists in the management of diabetes
    Chia, Chee W.
    Egan, Josephine M.
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2009, 2 : 37 - 49
  • [10] Transforming steatotic liver disease management: The emerging role of GLP-1 receptor agonists
    Jensen, Ellen L.
    Israelsen, Mads
    Krag, Aleksander
    HEPATOLOGY COMMUNICATIONS, 2024, 8 (11)
12345